Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lawrence, B. P.
Right arrow Articles by Kerkvliet, N. I.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lawrence, B. P.
Right arrow Articles by Kerkvliet, N. I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1998 Oxford University Press

other

Role of Altered Arachidonic Acid Metabolism in 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Immune Suppression in C57BI/6 Mice

B. Paige Lawrence*,1 and Nancy I. Kerkvliet{dagger}

*College of Pharmacology, Washington Stale University Pullman, Washington 99164 {dagger}Department of Agricultural Chemistry and Environmental Health Sciences Center, Oregon State University Corvallis, Oregon 97331

Received September 2, 1997; accepted December 12, 1997

One of the most sensitive targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is the immune system. Many arachidonic acid (AA) metabolites are potent immunoregulatory molecules, and in other systems, TCDD has been shown to alter AA metabolism. Furthermore, the genes for cyclooxygenase (cox) contain a dioxin response element, suggesting that exposure to TCDD may directly alter cox levels and prostaglandin (PG)E2 production. To test the hypothesis that TCDD induces immune suppression by altering the production of immunomodulatory AA metabolites, we examined the effects of TCDD on splenic AA release, LTB4 and PGE2 production, and cox-1 and cox-2 expression. Exposure of C57BI/6 mice to TCDD (15 (µg/kg) resulted in a 2-fold increase in the release of AA from spleen cell membranes, a 1.4-fold enhancement of LTB4 and PGE2 production in the spleen, and 3-fold higher PGE2 levels in the peritoneal cavity during the immune response to allogeneic P815 tumor cells. We examined the direct induction of cox-1 and cox-2 by TCDD and the indirect induction of cox-2 via TCDD-induced IL-1. Interestingly, exposure to TCDD did not alter message or protein levels of cox-1, cox-2, or IL-1 over the course of the response to P815. Various metabolic inhibitors were then used to address the in vivo role of TCDD-induced changes in AA metabolism. While these inhibitors blocked AA metabolism, they failed to affect the TCDD-induced suppression of either the cytotoxic T lymphocyte response to P815 tumor cells or antibody formation in response to sheep red blood cells. The lack of effect of TCDD on cox expression, combined with the failure of metabolic inhibitors to reverse the suppression caused by TCDD, supports the conclusion that TCDD immunotoxicity is likely not mediated by a direct effect on the production of immunomodulatory AA metabolites.

Key Words: TCDD; PGE2; cyclooxygenase; Ah receptor; immunotoxicity.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
S. Teske, A. A. Bohn, J. P. Hogaboam, and B. P. Lawrence
Aryl Hydrocarbon Receptor Targets Pathways Extrinsic to Bone Marrow Cells to Enhance Neutrophil Recruitment during Influenza Virus Infection
Toxicol. Sci., March 1, 2008; 102(1): 89 - 99.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Teske, A. A. Bohn, J. F. Regal, J. J. Neumiller, and B. P. Lawrence
Activation of the aryl hydrocarbon receptor increases pulmonary neutrophilia and diminishes host resistance to influenza A virus
Am J Physiol Lung Cell Mol Physiol, July 1, 2005; 289(1): L111 - L124.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.